论文信息 - Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study. - 字舞流文

Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study.

V. Bourgeois | J. Blanc | P. Michel | D. Malka | C. Neuzillet | J. Phelip | J. Edeline | J. Desramé | S. Manfredi | E. Barbier

[1] Pierre Michel,et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.

[2] D. Cunningham,et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. , 2010, The New England journal of medicine.

[3] J. Faivre,et al. Trends in incidence and management of gallbladder carcinoma , 2000, Cancer.